Alzheimer disease

1,672,300views

Alzheimer disease

Michael Kallsen

Michael Kallsen

Autosomal trisomies: Pathology review
Down syndrome (Trisomy 21)
Inheritance patterns
DNA damage and repair
DNA replication
Free radicals and cellular injury
Cell cycle
Selective permeability of the cell membrane
Colorectal polyps and cancer: Pathology review
Endometrial hyperplasia and cancer: Clinical
Lung cancer
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Breast cancer: Pathology review
Hypertension: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Arterial disease
Asthma
Atrial septal defect
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Myocardial infarction
Patent ductus arteriosus
Pericarditis and pericardial effusion
Peripheral artery disease
Pleural effusion
Pneumonia
Pulmonary edema
Restrictive lung diseases
Shock
Stroke volume, ejection fraction, and cardiac output
Tetralogy of Fallot
Dementia: Pathology review
Anxiety disorders: Clinical
Arteriovenous malformation
Bipolar and related disorders
Cauda equina syndrome
Cranial nerves
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Stroke: Clinical
Alzheimer disease
Diabetes mellitus: Pathology review
Abnormal uterine bleeding: Clinical
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Primary adrenal insufficiency
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Testosterone
Thyroid hormones
Benign prostatic hyperplasia
Anemia of chronic disease
Chronic leukemia
Coagulation disorders: Pathology review
Disseminated intravascular coagulation
Factor V Leiden
Hemophilia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Hypocalcemia
Hypokalemia
Inflammation
Innate immune system
Introduction to the immune system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Acute cholecystitis
Acute pancreatitis
Acute pyelonephritis
Alcohol-associated liver disease
Appendicitis
Autoimmune hepatitis
Biliary colic
Bowel obstruction
Celiac disease
Chronic cholecystitis
Chronic pyelonephritis
Chronic pancreatitis
Cirrhosis
Congenital disorders: Clinical
Crohn disease
Gastroesophageal reflux disease (GERD)
Irritable bowel syndrome
Lower urinary tract infection
Nephrotic syndromes: Pathology review
Peptic ulcer
Renal failure: Pathology review
Ulcerative colitis
Urinary tract infections: Pathology review
Viral hepatitis
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Skin cancer
Varicella zoster virus

Transcript

Watch video only

Content Reviewers

Dementia isn’t technically a disease, but more of a way to describe a set of symptoms like poor memory and difficulty learning new information, which can make it really hard to function independently.

Usually dementia’s caused by some sort of damage to the cells in the brain, which can be caused by a variety of diseases. Alzheimer’s disease, now referred to as Alzheimer disease, is the most common cause of dementia.

Alzheimer disease is considered a neurodegenerative disease, meaning it causes the degeneration, or loss, of neurons in the brain, particularly in the cortex. This, as you might expect, leads to the symptoms characteristic of dementia.

Although the cause of Alzheimer disease isn’t completely understood, two major players that are often cited in its progression are plaques and tangles.

Alright, so here we’ve got the cell membrane of a neuron in the brain. In the membrane, you’ve got this molecule called amyloid precursor protein, or APP, one end of this guy’s in the cell, and the other end’s outside the cell. It’s thought that this guy helps the neuron grow and repair itself after an injury.

Since APP’s a protein, just like other proteins, it gets used and over time it gets broken down and recycled.

Normally, it gets chopped up by an enzyme called alpha secretase and it’s buddy, gamma secretase.

This chopped up peptide is soluble and goes away, and everything’s all good.

If another enzyme, beta secretase, teams up with gamma secretase instead, then we’ve got a problem, and this leftover fragment isn’t soluble, and creates a monomer called amyloid beta.

These monomers tend to be chemically “sticky”, and bond together just outside the neurons, and form what are called beta-amyloid plaques—these clumps of lots of these monomers.

These plaques can potentially get between the neurons, which can get in the way of neuron-to-neuron signaling.

If the brain cells can’t signal and relay information, then brain functions like memory can be seriously impaired.

It’s also thought that these plaques can start up an immune response and cause inflammation which might damage surrounding neurons.

Amyloid plaque can also deposit around blood vessels in the brain, called amyloid angiopathy, which weakens the walls of the blood vessels and increases the risk of hemorrhage, or rupture and blood loss.

Here’s an image of amyloid plaque on histology, these clumps are buildups of beta amyloid, and this is happening outside the cell.

Another big part of alzheimer disease though, are tangles, and these are actually found inside the cell, as opposed to the beta-amyloid plaques.

Just like other cells, neurons are held together by their cytoskeleton, which is partly made up of microtubules, these track-like structures that essentially act like a minecart shipping nutrients and molecules along the length of the cell.

A special protein called tau makes sure that these tracks don’t break apart, kind of like railway ties.

Although again, it’s not completely understood, it’s thought that the beta amyloid plaque build-up outside the neuron, initiates pathways inside the neuron that leads to activation of kinase, an enzyme that transfers phosphate groups to the tau protein.

The tau protein then changes shape, stops supporting the microtubules, and clumps up with other tau proteins, and gets tangled, and leads to the other characteristic finding of Alzheimer disease–neurofibrillary tangles.

Neurons with tangles and non-functioning microtubules can’t signal as well, and sometimes end up undergoing apoptosis, or programmed cell death. Here’s an image of histology showing these neurofibrillary tangles formed inside the cell.

As neurons die, large scale changes start to take place in the brain, for one, the brain atrophies, or shrinks, and the gyri get narrower, which are the characteristic ridges of the brain.

As those get narrower, the sulci, which are the grooves between the gryi, get wider.

With atrophy, the ventricles, or fluid-filled cavities in the brain, get larger as well.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "Alzheimer's disease" BMJ (2009)
  5. "Early-onset Alzheimer's Disease: Nonamnestic Subtypes and Type 2 AD" Archives of Medical Research (2012)
  6. "Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies" Nature Neuroscience (2018)